Science 37 Holdings, Inc.

NasdaqCM:SNCE Stock Report

Market Cap: US$34.7m

Science 37 Holdings Management

Management criteria checks 2/4

Science 37 Holdings' CEO is Dave Coman, appointed in Nov 2019, has a tenure of 4.33 years. total yearly compensation is $8.06M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.89% of the company’s shares, worth $309.55K. The average tenure of the management team and the board of directors is 3.3 years and 2.4 years respectively.

Key information

Dave Coman

Chief executive officer

US$8.1m

Total compensation

CEO salary percentage6.8%
CEO tenure4.3yrs
CEO ownership0.9%
Management average tenure3.3yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks

Dec 18
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks

Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)

Apr 17
Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)

Science 37, Syapse team for faster patient enrollment in cancer trials

Aug 18

Science 37 reports Q2 mixed earnings; narrows FY22 guidance

Aug 11

Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

May 13
Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Apr 11
Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Science 37: Pioneering Decentralized Clinical Trials

Jan 02

We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Nov 04
We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Dave Coman's remuneration changed compared to Science 37 Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$125m

Jun 30 2023n/an/a

-US$134m

Mar 31 2023n/an/a

-US$121m

Dec 31 2022US$8mUS$550k

-US$51m

Sep 30 2022n/an/a

-US$50m

Jun 30 2022n/an/a

-US$41m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$8mUS$435k

-US$94m

Sep 30 2021n/an/a

-US$42m

Jun 30 2021n/an/a

-US$35m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$1mUS$400k

-US$32m

Compensation vs Market: Dave's total compensation ($USD8.06M) is above average for companies of similar size in the US market ($USD662.89K).

Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.


CEO

Dave Coman (53 yo)

4.3yrs

Tenure

US$8,062,854

Compensation

Mr. David Coman, also known as Dave, has been Chief Executive Officer of Science 37 Holdings, Inc. (formerly known as Science 37, Inc.) since November 2019 and serves as its Director since October 2021. He...


Leadership Team

NamePositionTenureCompensationOwnership
David Coman
CEO & Director4.3yrsUS$8.06m0.89%
$ 309.5k
Christine Pellizzari
Chief Legal & Human Resources Officer and Secretary2.7yrsUS$4.65m0.24%
$ 83.4k
Darcy Forman
Chief Delivery Officer4.2yrsUS$3.93m0.26%
$ 90.6k
Mike Zaranek
Chief Financial Officer3.9yrsno data0.15%
$ 52.2k
Irena Lambridis
VP and Head of Quality Assurance & Complianceless than a yearno datano data
Margie Kooman
Vice President of Marketing & Communications3.8yrsno datano data
Drew Bustos
Chief Strategy & Marketing Officerno datano datano data
Jonathan Cotliar
Chief Medical Officer4.8yrsUS$486.60k0.69%
$ 240.9k
Michael Shipton
Chief Commercial Officer1.5yrsno data0.059%
$ 20.4k
Tyler Van Horn
VP of Corporate Strategy & Chief of Staff2.2yrsno datano data
Erica Prowisor
Senior VP of Patient & Provider Networksless than a yearno datano data

3.3yrs

Average Tenure

51.5yo

Average Age

Experienced Management: SNCE's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
David Coman
CEO & Director2.4yrsUS$8.06m0.89%
$ 309.5k
John Hubbard
Independent Director3.5yrsUS$180.00k0.034%
$ 11.8k
Robert Faulkner
Independent Chairman of the Board2.4yrsUS$215.00k0.034%
$ 11.8k
Paul von Autenried
Independent Director1.5yrsUS$93.33k0.038%
$ 13.2k
Bhooshitha De Silva
Independent Director2.4yrsno datano data
Neil Tiwari
Independent Director2.4yrsUS$165.00k0.034%
$ 11.8k
Emily Rollins
Independent Director2.4yrsUS$185.00k0.034%
$ 11.8k

2.4yrs

Average Tenure

53yo

Average Age

Experienced Board: SNCE's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.